Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-12-13

Clinical Trial Update: Probiotic (Visbiome) for Gulf War Illness [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Visbiome probiotic in Gulf War Illness, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Visbiome

Snippet

Sponsor: Ashok Tuteja | Conditions: Gulf War Illness | Phase 2, Phase 3 | Status: UNKNOWN